Cite
HARVARD Citation
Cai, Z. et al. (2022). Dynamics of minimal residual disease defines a novel risk-classification and the role of allo-HSCT in adult Ph-negative B-cell acute lymphoblastic leukemia. Leukemia & lymphoma. 63 (13), pp. 3181-3190. [Online].